COMMUNIQUÉS West-GlobeNewswire

ContraVir Pharmaceuticals Announces $10.8 Million in Expected Gross Proceeds from Recently Expired Rights Offering
29/06/2018
EDISON, N.J., June 29, 2018 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV) (“ContraVir” or the “Company”), a biopharmaceutical company focused on the development and commercialization of therapeutic [...]
Extendicare Announces Timing of 2018 Second Quarter Results and Conference Call
29/06/2018
MARKHAM, Ontario, June 29, 2018 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX:EXE) announced today that it plans to release its financial results for the second quarter of 2018, after market [...]
APEIRON, the Medical University of Vienna and the Institute of Molecular Biotechnology Sign Licensing Agreement for a New Checkpoint Inhibitor
29/06/2018
APEIRON strengthens its proprietary Cbl-b portfolio with cutting edge immunotherapy technology developed at IMBA VIENNA, Austria, June 29, 2018 (GLOBE NEWSWIRE) -- APEIRON Biologics AG, a company focused on cancer [...]
Change in number of shares and votes in Saniona AB (publ)
29/06/2018
PRESS RELEASE June 29, 2018 During June, the registered number of shares and votes in Saniona AB (publ) (“Saniona”) has increased due to conversion of convertible notes issued pursuant to the convertible notes funding [...]
Akers Biosciences Requests Temporary Suspension of Trading on London Stock Exchange
29/06/2018
THOROFARE, N.J., June 29, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, announces that the Company [...]
Dermira Receives FDA Approval for Qbrexza™ (glycopyrronium) Cloth to Treat Primary Axillary Hyperhidrosis
29/06/2018
Qbrexza is the first FDA-approved, once-daily, topical prescription treatment indicated for people with primary axillary hyperhidrosis, also known as excessive underarm sweating The chronic, medical skin condition is [...]
FDA Lifts Clinical Hold so MYC Inhibitor APTO-253 Can Return to Phase 1b Trial In Patients With Hematologic Cancers
29/06/2018
SAN DIEGO and TORONTO, June 29, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ:APTO) (TSX:APS) today announced that the U.S. Food and Drug Administration (FDA) has notified the company that it has lifted the [...]
RavenQuest Announces Media and Investor Open House at Edmonton Facility
29/06/2018
VANCOUVER, British Columbia, June 29, 2018 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (CSE:RQB) (OTCQB:RVVQF) (Frankfurt:1IT) (the “ Company ” or “ RavenQuest ”) is pleased to announce it will hold a media and investor [...]
Sanofi: Availability of the Pre-quarterly Results Communication
29/06/2018
Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Availability of the Pre-quarterly Results Communication Paris, France - June 29, 2018 - Sanofi announced today that its Pre-Quarterly Results Communication [...]
Sanofi : Mise en ligne du document «Pre-quarterly Results Communication »
29/06/2018
Communiqué de presse Source : Sanofi (EURONEXT: SAN) (NYSE: SNY) Mise en ligne du document «Pre-quarterly Results Communication » Paris, France - Le 29 juin 2018 - Sanofi annonce la mise en ligne sur l'espace [...]
Shire plc : Rule 2.9 Announcement
29/06/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 29 June 2018 Shire [...]
Chi-Med to Announce 2018 Half-Year Financial Results
29/06/2018
LONDON, June 29, 2018 (GLOBE NEWSWIRE) -- Hutchison China MediTech Limited (“Chi-Med”) (AIM:HCM) (Nasdaq:HCM) will be announcing its interim results for the six months ended June 30, 2018 on Friday, July 27, 2018 at 7: [...]
Dividend payment ex-date of AS “Olainfarm”
29/06/2018
Dividend payment ex-date of AS “Olainfarm” AS “Olainfarm” (OLF1R, ISIN code LV0000100501) will close the list of shareholders for dividend payment on July 4, 2018 at the end of the working day of the Nasdaq CSD Latvian [...]
NICOX : Point sur les récents progrès de ses programmes et activités clés
29/06/2018
Communiqué de presse Nicox : Point sur les récents progrès de ses programmes et activités clés ............................................. 29 juin 2018 - diffusion à 7h30 Sophia Antipolis, France Nicox S.A. (Euronext [...]
Nicox Highlights Recent Progress with Key Programs and Activities
29/06/2018
Press Release Nicox Highlights Recent Progress with Key Programs and Activities .............................................. June 29, 2018 - release at 7:30 am CET Sophia Antipolis, France Nicox SA (Euronext Paris: [...]
Sensorion Shows Protective Effect of SENS-401 in Hearing Loss Models
29/06/2018
MONTPELLIER, France, June 29, 2018 (GLOBE NEWSWIRE) -- Sensorion ( FR 0012596468 – ALSEN ), a biotech company specializing in the treatment of inner ear diseases , presented data showing that its clinical stage product- [...]
VALNEVA Announces Successful Outcome of its AGM and Renewal of the Term of Office of its Management Board Members
29/06/2018
Valneva Announces Successful Outcome of its AGM and Renewal of the Term of Office of its Management Board Members Lyon (France), June 29, 2018 - Valneva SE ("Valneva" or "the Company"), a fully integrated, commercial [...]
VALNEVA annonce le succès de son Assemblée Générale et le renouvellement des mandats de son directoire
29/06/2018
Valneva annonce le succès de son Assemblée Générale et le renouvellement des mandats de son directoire Lyon (France), June 29, 2018 - Valneva SE ("Valneva" ou "le Groupe"), société de biotechnologie dédiée au [...]
Sanofi: CHMP recommends approval of Cablivi(TM) (caplacizumab)
29/06/2018
Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) CHMP recommends approval of Cablivi(TM) (caplacizumab) First therapeutic to receive positive CHMP opinion for treatment of a rare blood disorder called acquired [...]

Pages